The Power of Line-Extension Tactics in Your Counter-Generics Strategy

Key Finding #4 from our Counter-Generics and Biosimilar Threats research:

Short-term strategies are still the most popular, but line-extension tactics gaining favor.

Over the past three years, short-term strategies, including litigation and defensive pricing, have led the way in popularity. Responding companies used each tactic 60% and 57%, respectively. Neither tactic requires very long to move from planning to completion. A large majority Continue reading